跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,009 条关于
“BKV nephropathy”
全部
4,009
临床试验
3,308
药物
215
机构
190
资讯
296
去年
Memo Therapeutics Demonstrates Therapeutic Antibodies Can Cross Kidney Barrier, Supporting BK Virus Treatment Approach
去年
Memo Therapeutics Completes Enrollment in Phase II Trial of Potravitug for BK Viremia
去年
Memo Therapeutics AG Completes Enrollment in Phase II Trial of Potravitug for BK Viremia
去年
SpikImm Secures Worldwide License for Anti-BK Virus Monoclonal Antibodies to Protect Transplant Patients
去年
Memo Therapeutics AG Completes Enrollment in Phase II Trial of Potravitug for BK Viremia
去年
Memo Therapeutics AG Completes Enrollment in Phase II Trial of Potravitug for BK Viremia
去年
Vera Therapeutics Receives FDA Breakthrough Therapy Designation for Atacicept in IgAN
去年
Study Calls for Optimization of High-Cost IVIG Therapy in BK Nephropathy Treatment
去年
Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer
去年
Memo Therapeutics to Present Phase II Results for First-in-Class BK Polyomavirus Treatment at World Transplant Congress
第 1 页,共 30 页
上一页
下一页